The last two weeks have seen unprecedented scenes in respect of the spread of COVID-19 and in the last few days, the reaction to this in stock markets globally.
So what are we doing at PPS and what should you, as our clients, be doing?
Open for Business
PPS remains fully open for business to our clients. Our Business Continuity Plan is in action, and whilst all of our offices currently remain open, we also have the ability for all staff to work remotely which ensures that you, our clients, continue to have access to us at all times. Our usual email addresses and telephone numbers will remain the method of contact.
Our advisers are still currently travelling to see clients, and our clients are welcome at our offices, but where you may feel this is inappropriate, we equally have the ability to conduct meetings remotely using Skype, FaceTime or the good old-fashioned telephone.
Documents can be scanned and sent to you by email and we have the facility for these to be signed electronically, so that we can continue to manage your personal affairs.
What should you do?
Please remember first of all, that all investments we make are actively managed by Fund Managers on your behalf. They are working hard for you to ensure that the impact of the stock markets is limited as far as possible on your portfolios.
Stock markets fall and rise, and investments we make for you are for the medium to long term — a loss is only suffered if you surrender your investment. Indeed, many investment managers are looking at this as an opportunity to invest rather than to disinvest as there is considerable value to be had in the market at this time.
In addition, we are of course approaching the tax year end (5 April) and we will continue to work hard to ensure that tax planning we are currently discussing with you is being completed in time.
Your adviser is available to discuss any matters that are concerning you, and indeed to continue with business as usual. Please do not hesitate to contact them.
We will of course continue to keep you informed of developments.